1011487-94-7 Usage
General Description
3-Pyridazinemethanol, 6-chloro- is a chemical compound with the molecular formula C5H4ClNO. It is a white to off-white crystalline solid that is primarily used as an intermediate in the production of pharmaceuticals and agrochemicals. 3-PYRIDAZINEMETHANOL, 6-CHLORO- is known for its role as a building block in the synthesis of various active pharmaceutical ingredients. It is also used in the manufacturing of pesticides, herbicides, and fungicides. Additionally, 3-Pyridazinemethanol, 6-chloro- has potential applications in the field of organic chemistry and materials science due to its unique chemical structure and reactivity. However, it is important to handle this chemical with care as it may pose potential hazards to human health and the environment.
Check Digit Verification of cas no
The CAS Registry Mumber 1011487-94-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,1,1,4,8 and 7 respectively; the second part has 2 digits, 9 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1011487-94:
(9*1)+(8*0)+(7*1)+(6*1)+(5*4)+(4*8)+(3*7)+(2*9)+(1*4)=117
117 % 10 = 7
So 1011487-94-7 is a valid CAS Registry Number.
1011487-94-7Relevant articles and documents
CONTINUOUS ARYCYCLIC COMPOUND
-
Page/Page column 82, (2012/06/30)
This is to provide a continuous arycyclic compound having a DGAT1 inhibitory activity, and useful for prophylaxis and/or treatment of obesity or hyperlipidemia caused by obesity, hypertriglyceridemia, lipid metabolism disorder, fatty liver, hypertension,
4-OXO-1,4-DIHYDROQUINOLINE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS
-
Page/Page column 30, (2009/12/05)
The present invention is directed to compounds of formula (I) which are M1 receptor positive allosteric modulators and that are useful in the treatment of diseases in which the M1 receptor is involved, such as Alzheimer's disease, schizophrenia, pain or sleep disorders. The invention is also directed to pharmaceutical compositions comprising the compounds, and to the use of the compounds and compositions in the treatment of diseases mediated by the M1 receptor.